The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said Friday.
of the drug found that it delivered pain relief to some migraine sufferers in as little as 15 minutes.
The treatment for a condition generally tackled with orally taken medicines was double-blind tested on a sample of 1,405 people, with half taking a single spray dose and the remainder receiving a placebo.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Pfizer says the FDA has approved its migraine nasal spray ZavzpretDrugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.
Les mer »
Pfizer's fast-acting migraine nasal spray approved by FDAThe nasal spray is designed for quick relief of migraine headaches for those who can't take pills or injections.
Les mer »
New nasal spray approved to treat migraines in adults, Pfizer saysPfizer said the Food and Drug Administration has approved its new nasal spray for adults with migraines.
Les mer »
New nasal spray approved to treat migraines in adults, Pfizer saysPfizer said the Food and Drug Administration has approved its new nasal spray for adults with migraines.
Les mer »
Migraine nasal spray from Pfizer snags FDA approval for expected summer launchThe FDA has approved Pfizer's nasal spray to treat migraines in adults. The medication, called Zavzpret, is expected to be available via a doctor's prescription in July 2023.
Les mer »
FDA approves nasal spray to treat migrainesZavzpret is the first nasal spray approved to block calcitonin gene-related peptide, a protein believed to contribute to migraines.
Les mer »